Global Interventional Oncology Devices Market, By Product Type (Embolization Devices, Ablation Devices, Support Devices, Next-Gen Devices), Cancer Type (Liver Cancer, Prostate Cancer, Breast Cancer, Lung Cancer, Bone Cancer, Kidney Cancer, Others), Procedure (Thermal Tumor Ablation, Non-Thermal Tumor Ablation, Transcatheter Arterial Chemoembolization, Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy, Transcatheter Arterial Embolization/Bland Embolization), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights of Interventional Oncology Devices
Interventional oncology devices market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to USD 3.75 billion by 2028 and will grow at a CAGR of 6.95% in the above mentioned forecast period.
Interventional oncology largely deals with the treatment of a variety of cancers with the help of targeted minimally invasive procedures that are performed under image guidance. Also, it has faster recovery time when compared to the conventional open surgeries.
The rising public-private funding and government support for interventional oncology is amongst the important factors intensifying the growth and demand of interventional oncology devices market. In addition, the rapid technological advancements in interventional oncology and growth of the target patient population are also contributing to the growth in the global market over the forecast period of 2021 to 2028. Also the increasing patient preference for minimally invasive procedures is also enhancing the growth of the market. Furthermore, the rapid increase in the incidence rate of cancer across the world and improved funding from the government in developed countries are also one of the significant factors fueling the growth of the interventional oncology devices market. Favorable reimbursement scenario for interventional oncology treatment will make sure high industry growth over the forecast period.
The growing awareness about the benefits of interventional oncology as well as the increasing product launches and escalating mergers and acquisitions amongst the industry players are also offering significant growth opportunities for the market in the forecast period of 2021 to 2028.
However, the product recalls and lack of clinical evidence for localized region treatment as well as unfavorable regulations will curb the growth of the interventional oncology devices market, whereas the inadequate clinical data to support therapeutic efficiency and dearth of well-trained and skilled oncologists have the potential to challenge the growth of the interventional oncology devices market.
This interventional oncology devices market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on interventional oncology devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Interventional Oncology Devices Market Scope and Market Size
Interventional oncology devices market is segmented on the basis of product type, cancer type and procedure. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- Based on product type, the interventional oncology devices market is segmented into embolization devices, ablation devices, support devices and next-gen devices. Embolization devices have further been segmented into transcatheter arterial radioembolization, transcatheter arterial chemoembolization and transcatheter arterial embolization. Ablation devices have further been segmented into radiofrequency ablation, microwave ablation and cryoablation. Support devices have further been segmented into catheters and guidewires. Next-gen devices have further been segmented into irreversible electroporation ablation, percutaneous ethanol ablation, high-intensity focused ultrasound, laser ablation, photothermal ablation and theranostics.
- On the basis of cancer type, the interventional oncology devices market is segmented into liver cancer, prostate cancer, breast cancer, lung cancer, bone cancer, kidney cancer and others.
- The procedure segment of interventional oncology devices market is segmented into thermal tumor ablation, non-thermal tumor ablation, transcatheter arterial chemoembolization, transcatheter arterial radioembolization/selective internal radiation therapy and transcatheter arterial embolization/bland embolization.
Interventional Oncology Devices Market Country Level Analysis
Interventional oncology devices market is analyzed and market size insights and trends are provided by country, product type, cancer type and procedure as referenced above.
The countries covered in the interventional oncology devices market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa(MEA), Brazil, Argentina and Rest of South America as part of South America.
North America region leads the interventional oncology devices market owing to the rapid advancements in technology and easy affordability to minimally invasive procedures for the efficient management of cancer in the developed countries within the region. Asia-Pacific is expected to expand at a significant growth rate over the forecast period of 2021 to 2028 because of the rising adoption of interventional oncology procedures along with rising incidence of cancer and the increasing geriatric population within this particular region.
The country section of the interventional oncology devices market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
Interventional oncology devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for interventional oncology devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the interventional oncology devices market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Interventional Oncology Devices Market Share Analysis
Interventional oncology devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to interventional oncology devices market.
The major players covered in the interventional oncology devices market report are Medtronic, Boston Scientific Corporation, Terumo Europe NV, Merit Medical Systems, Sirtex Medical Limited, AngioDynamics, Johnson & Johnson Services, Inc., Teleflex Incorporated, Cook, Varian Medical Systems, Inc., Eckert & Ziegler BEBIG, 3M, MedWaves, Inc., IMBIOTECHNOLOGIES LTD., Trod Medical, Smiths Medical, NEWTECH MEDICAL DEVICES, IceCure Medical Ltd, Accuray Incorporated and Sanarus, among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-